Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer
Status:
Active, not recruiting
Trial end date:
2022-05-24
Target enrollment:
Participant gender:
Summary
This phase I trial studies the molecular profile of breast cancer in Ugandan patients with
stage IIB-III breast cancer. Creating a molecular profile of breast cancer my help doctors
learn more about biological factors associated with breast cancer in Ugandan patients with as
well as measure the benefits of locally available diagnostic studies and the possibility of
providing treatment via oral medication.